Alterations in cell adhesion molecules and other biomarkers of cardiovascular disease in patients with metabolic syndrome

作者：Rosso Leonardo Gomez; Benitez Maria Belen; Fornari Maria Cecilia; Berardi Vanina; Lynch Santiago; Schreier Laura; Wikinski Regina; Cuniberti Luis; Brites Fernando^*

来源：Atherosclerosis, 2008, 199(2): 415-423.

DOI：10.1016/j.atherosclerosis.2007.11.007

• metabolic syndrome
• atherosclerosis
• inflammation
• biomarkers
• adhesion molecules
• adiponectin

Metabolic syndrome is considered it hyperinsulinemic and inflammatory state closely associated to endothelial dysfunction causing all increased incidence of ischemic cardiovascular events and high mortality. The main objective of the present Study was to determine whether leukocitary and Soluble cell adhesion molecules were altered in patients with metabolic syndrome in comparison with control Subjects. Cell adhesion molecules, mainly of leukocitary location, have been not previously evaluated in specifically designed cross-sectional Studies involving male patients with metabolic syndrome. Moreover, other circulating markers of different candidate atherogenic risk parameters were also studied and the potential existence of a progressive relation between the number of metabolic syndrome components and the above mentioned biomarkers was analyzed. Thirty one male patients with metabolic syndrome (ATPIII definition) and 56 male control subjects were studied. We evaluated different markers of insulin resistance, inflammation and atherosclerosis, its well as protective factors. Patients with metabolic syndrome showed (a) hypoadiponectinemia (4551 +/- 2302 ng/ml vs. 5865 +/- 2548 ng/ml, respectively; p < 0.05), (b) an atherogenic lipid and lipoprotein profile, (c) altered HDL chemical composition accompanied by higher cholesteryl ester-triglyceride interchange carried Out by CETP. (d) diminished Lp-PLA(2) activity (6.5 +/- 1.9 vs. 7.3 +/- 2.2, p < 0.05, respectively). antioxidant enzyme related with LDL oxidation. which was positively associated with QUICKI and negatively with VCAM-1 and lymphocyte CD18, and (e) high soluble (VCAM-1 : 17 +/- 5 vs. 13 +/- 4 ng/ml, respectively: p < 0.0005) and leukocyte adhesion molecule expression (monocyte CD54: 52 +/- 15 vs. 45 +/- 12 arbitrary units, respectively; p < 0.0005 and lymphocyte CD49d: 312 +/- 56 vs. 284 +/- 64 arbitrary units. respectively; p < 0.05). The increment in leukocyte and Soluble cell adhesion molecules, crucial for leukocyte interaction with the endothelium and migration into the artery wall, in combination with the other disorders described above reinforce the presence of a clinical status with high propensity to type 2 diabetes and atherosclerotic cardiovascular disease.

• 出版日期2008-8